Abstract
Background
Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affects subsequent cancer treatment. This study investigated the incidence and risk factors for early and late infection after TIVAP implantation.
Methods
From January 2013 to December 2018, all adult cancer patients who received TIVAP implantation in Taipei Medical University Shuang-Ho Hospital were reviewed. We evaluated the incidence of TIVAP-related infection, patient characteristics, and bacteriologic data. Univariable analysis and multiple logistic regression analysis were used to evaluate the risk factors of TIVAP-related infection.
Results
A total of 3001 TIVAPs were implanted in 2897 patients, and the median follow-up time was 424 days (range: 1–2492 days), achieving a combined total of 1,648,731 catheter days. Thirty-one patients (1.0%) had early infection and 167 (5.6%) patients had late infection. In multivariate analysis, TIVAP combined with other surgeries (p = 0.03) and inpatient setting (p < 0.001) was the risk factor of early infection, and TIVAP combined with other surgeries (p = 0.007), hematological cancer (p = 0.03), and inpatient setting (p < 0.001) was the risk factor of late infection.
Conclusion
Inpatient TIVAP implantation and TIVAP implantation combined with other surgeries are associated with high rates of TIVAP-related early and late infections.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, Tung-Cheng Chang, upon reasonable request.
References
Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712
Zerati AE, Figueredo TR, de Moraes RD, da Cruz AM, da Motta-Leal Filho JM, Freire MP et al (2016) Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients. J Vasc Surg Venous Lymphat Disord 4:200–205
Lebeaux D, Larroque B, Gellen-Dautremer J, Leflon-Guibout V, Dreyer C, Bialek S et al (2012) Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine 9:309–318
Vidal M, Genillon JP, Forestier E, Trouiller S, Pereira B, Mrozek N et al (2016) Outcome of totally implantable venous-access port-related infections. Med Mal Infect 46:32–38
Tang L, Kim CY, Martin JG, Pabon-Ramos WM, Sag AA, Suhocki PV et al (2020) Length of stay predicts risk of early infection for hospitalized patients undergoing central venous port placement. J Vasc Interv Radiol 31:454–461
Voog E, Campion L, du Rusquec P, Bourgeois H, Domont J, Denis F et al (2018) Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Support Care Cancer 26:81–89
Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Yazdanpanah Y (2007) Risk factors for early catheter-related infections in cancer patients. Cancer 110:1586–1592
Shim J, Seo TS, Song MG, Cha IH, Kim JS, Choi CW et al (2014) Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol 15:494–500
Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmüller R et al (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care 19:676–681
Pandey N, Chittams JL, Trerotola SO (2013) Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement. J Vasc Interv Radiol 24:849–854
Erinjeri JP, Fong AJ, Kemeny NE, Brown KT, Getrajdman GI, Solomon SB (2011) Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 117:1296–1301
Bamba R, Lorenz JM, Lale AJ, Funaki BS, Zangan SM (2014) Clinical predictors of port infections within the first 30 days of placement. J Vasc Interv Radiol 25:419–423
Zhang S, Kobayashi K, Faridnia M, Skummer P, Zhang D, Karmel MI (2018) Clinical predictors of port infections in adult patients with hematologic malignancies. J Vasc Interv Radiol 29:1148–1155
Stone AM, Tucci VJ, Isenberg HD, Wise L (1976) Wound infection: a prospective study of 7519 operations. Am Surg 42:849–852
Drake CT, Goldman E, Nichols RL, Piatriszka K, Nyhus LM (1977) Environmental air and airborne infections. Ann Surg 185:219–223
Hsieh CC, Weng HH, Huang WS, Wang WK, Kao CL, Lu MS et al (2009) Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol 15:4709–4714
Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P et al (2009) Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port. Med Mal Infect 39:252–258
Doyon L, Moreno-Koehler A, Ricciardi R, Nepomnayshy D (2016) Resident participation in laparoscopic Roux-en-Y gastric bypass: a comparison of outcomes from the ACS-NSQIP database. Surg Endosc 30:3216–3224
Relles DM, Burkhart RA, Pucci MJ, Sendecki J, Tholey R, Drueding R et al (2014) Does resident experience affect outcomes in complex abdominal surgery? Pancreaticoduodenectomy as an example. J Gastrointest Surg 18:279–285
Schreckenbach T, Münch I, El Youzouri H, Bechstein WO, Habbe N (2019) The safety level of total central venous access port implantation performed by residents. J Surg Educ 76:182–192
Wang T, Wang H, Yang DL, Jiang LQ, Zhang LJ, Ding WY (2017) Factors predicting surgical site infection after posterior lumbar surgery: a multicenter retrospective study. Medicine (Baltimore) 96:e6042
Karim H, Chafik K, Karim K, Moez H, Makki AM, Adnen el-H et al (2000) Risk factors for surgical wound infection in digestive surgery. Retrospective study of 3,000 surgical wounds. Tunis Med 78:634–640
Nocito A, Wildi S, Rufibach K, Clavien PA, Weber M (2009) Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports. Br J Surg 96:1129–1134
Hüttner FJ, Bruckner T, Hackbusch M, Weitz J, Bork U, Kotschenreuther P et al (2020) Primary open versus closed implantation strategy for totally implantable venous access ports: the multicentre randomized controlled PORTAS-3 Trial (DRKS 00004900). Ann Surg. https://doi.org/10.1097/SLA.0000000000003705
Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B et al (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146–159
Author information
Authors and Affiliations
Contributions
Conception and design: Min-Hsuan Yen and Tung-Cheng Chang. Acquisition of data: Min-Hsuan Yen and Tung-Cheng Chang. Analysis and interpretation data: Min-Hsuan Yen, Kee-Thai Kiu and Tung-Cheng Chang. Writing, review, and revision of the manuscript: Tung-Cheng Chang.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the ethics committee of the Taipei Medical University (approval number: N201801072) and performed according to the declaration of Helsinki of 1964 and its later amendments or comparable ethical standards.
Informed consent
Informed consent was not applicable due to the retrospective nature of this study.
Conflict of interest
The authors declare no competing of interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chang, TC., Yen, MH. & Kiu, KT. Incidence and risk factor for infection of totally implantable venous access port. Langenbecks Arch Surg 407, 343–351 (2022). https://doi.org/10.1007/s00423-021-02328-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-021-02328-0